Benign partial epilepsy with secondarily generalized seizures in infancy

Benign partial epilepsy with secondarily generalized seizures in infancy (BPEI) is a rare, age-related epilepsy syndrome that typically presents during the first two years of life. It belongs to the group of benign infantile epilepsies and is characterized by focal (partial) seizures that may spread to become secondarily generalized tonic-clonic seizures. The seizures primarily affect the nervous system, with episodes that can include motor manifestations such as limb jerking, deviation of the eyes or head, and sometimes progression to bilateral convulsive activity. Between seizures, affected infants typically show normal neurological development and normal findings on brain imaging (MRI). Electroencephalography (EEG) may show focal epileptiform discharges during the ictal period but is often normal or near-normal interictally. The condition is considered benign because seizures generally respond well to standard antiepileptic medications and tend to remit spontaneously during early childhood, usually by age 2 to 3 years. Commonly used treatments include antiepileptic drugs such as carbamazepine or valproate, which are typically effective in controlling seizures. Long-term neurodevelopmental outcomes are generally favorable, with most children achieving normal cognitive and motor milestones. A family history of benign infantile seizures may be present in some cases, suggesting a genetic predisposition. This condition should be distinguished from other more severe infantile epilepsy syndromes that carry a less favorable prognosis, making accurate diagnosis important for appropriate counseling and management.

Common questions about Benign partial epilepsy with secondarily generalized seizures in infancy